share_log

Silo Pharma Announces Results From Preclinical Study On SPC-15, Highlighting Proposed Efficacy Of Combining SPC-15 With An NMDAR Antagonist

Silo Pharma Announces Results From Preclinical Study On SPC-15, Highlighting Proposed Efficacy Of Combining SPC-15 With An NMDAR Antagonist

Silo Pharma宣佈了關於SPC-15的臨床前研究結果,強調將SPC-15與NMDAR拮抗劑結合的預期療效。
Benzinga ·  11/18 08:42

Silo Pharma Announces Results From Preclinical Study On SPC-15, Highlighting Proposed Efficacy Of Combining SPC-15 With An NMDAR Antagonist

Silo Pharma宣佈了關於SPC-15的臨床前研究結果,強調將SPC-15與NMDAR拮抗劑結合的預期療效。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論